TY - JOUR
T1 - Skin cancer screening behaviours among individuals with a strong family history of malignant melanoma
AU - Kasparian, N. A.
AU - McLoone, J. K.
AU - Meiser, B.
AU - Butow, P. N.
AU - Simpson, J. M.
AU - Mann, G. J.
PY - 2010/11/9
Y1 - 2010/11/9
N2 - Background:This study examined the prevalence and correlates of skin cancer screening behaviours among individuals at high risk of developing melanoma due to strong family history.Methods:A total of 120 individuals with a known family-specific CDKN2A mutation (72% response rate) completed a self-report questionnaire assessing annual frequency of skin self-examination (SSE), clinical skin examination (CSE) and a variety of potential demographic, clinical and psychosocial correlates.Results:In the past 12 months, 50% of participants reported engaging in SSE at least four times, and 43% of participants had undergone at least one CSE. Engagement in SSE was associated with doctor recommendation (Β1.77, P0.001), confidence in one's ability to perform SSE (Β1.44, PP<0.0001), positive beliefs about melanoma treatment (Β0.77, P<0.002) and intention to perform SSE in the future (Β1.69, P0.0001). These variables accounted for 59% of the variance in SSE behaviour. Further, information-seeking style moderated the relationship between anxiety and SSE (Β1.02, P<0.004). Annual uptake of CSE was associated with doctor recommendation (Β2.21, P=0.0001) and intention to undergo CSE in the future (Β1.19, P<0.001).Conclusion:In comparison with clinical guidelines, it appears that individuals at high risk of developing melanoma engage in suboptimal levels of skin surveillance. Improved doctor-patient communication, as well as psycho-education and behavioural support, may be viable means of improving early skin cancer detection behaviours in this high-risk population.
AB - Background:This study examined the prevalence and correlates of skin cancer screening behaviours among individuals at high risk of developing melanoma due to strong family history.Methods:A total of 120 individuals with a known family-specific CDKN2A mutation (72% response rate) completed a self-report questionnaire assessing annual frequency of skin self-examination (SSE), clinical skin examination (CSE) and a variety of potential demographic, clinical and psychosocial correlates.Results:In the past 12 months, 50% of participants reported engaging in SSE at least four times, and 43% of participants had undergone at least one CSE. Engagement in SSE was associated with doctor recommendation (Β1.77, P0.001), confidence in one's ability to perform SSE (Β1.44, PP<0.0001), positive beliefs about melanoma treatment (Β0.77, P<0.002) and intention to perform SSE in the future (Β1.69, P0.0001). These variables accounted for 59% of the variance in SSE behaviour. Further, information-seeking style moderated the relationship between anxiety and SSE (Β1.02, P<0.004). Annual uptake of CSE was associated with doctor recommendation (Β2.21, P=0.0001) and intention to undergo CSE in the future (Β1.19, P<0.001).Conclusion:In comparison with clinical guidelines, it appears that individuals at high risk of developing melanoma engage in suboptimal levels of skin surveillance. Improved doctor-patient communication, as well as psycho-education and behavioural support, may be viable means of improving early skin cancer detection behaviours in this high-risk population.
KW - anxiety
KW - clinical skin examination
KW - family history
KW - genetics
KW - melanoma
KW - skin self-examination
UR - http://www.scopus.com/inward/record.url?scp=78149471150&partnerID=8YFLogxK
U2 - 10.1038/sj.bjc.6605942
DO - 10.1038/sj.bjc.6605942
M3 - Article
SN - 0007-0920
VL - 103
SP - 1502
EP - 1509
JO - British Journal of Cancer
JF - British Journal of Cancer
IS - 10
ER -